Carregant...

ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer

AIM: To determine the influence of excision repair cross complementing group 1 (ERCC1) codon 118 polymorphism and mRNA level on the clinical outcome of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. METHODS: Eighty-nine gastric cancer patients treated with oxalipatin-b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Huang, Zhao-Hui, Hua, Dong, Du, Xiang, Li, Li-Hua, Mao, Yong, Liu, Zhi-Hui, Song, Ming-Xu, Zhou, Xi-Ke
Format: Artigo
Idioma:Inglês
Publicat: The WJG Press and Baishideng 2008
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2766125/
https://ncbi.nlm.nih.gov/pubmed/19009659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.6401
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!